Latest News & Updates
The GLP-1 market is on track to reach over $30 billion by 2030. With unebbing market demand, IP disputes, and a microscope on advertising practices, it’s critical to stay up-to-date on all the legislative and litigative threats facing GLP-1 manufacturers today.
Join industry leaders in-person in New York City for this timely event that will cover everything from advertising to mass torts to peptides.
As the competitive landscape grows more complex, and litigation gets underway, don’t miss the chance to benchmark your approach, manage risk, and engage in critical discussions with peers and policymakers at the forefront of the GLP-1 boom.
View Agenda
Conference Co-Chairs
Julie Dohm
Partner
Covington & Burling LLP
Kyle Faget
Partner
McDermott Will & Schulte
Featured Speakers
Kalah Auchincloss
President
Canal Row Advisors
Scott Brunner
Chief Executive Officer
Alliance for Pharmacy Compounding
Karen McDonnell
VP, Global Head Legal Portfolio and R&D
Sandoz Inc.
Phyllis Hurwitz Marcus
Vice President, National Advertising Division
BBB National Programs
Norman Petty
General Counsel and EVP, Business Affairs
Noom Inc.
Join Our Companion Event
Biosimilars & Innovator Biologics
June 2–3, 2026 • 3 Times Square, New York, NY
Join key industry leaders to navigate biosimilars’ evolving legal, regulatory, and commercial challenges.
Gain critical insights on BPCIA, patent strategies, and future litigation. Explore our co-located event, the Biosimilars & Innovator Biologics Summit, for more key developments.
Learn MoreSponsors & Partners
Supporting Sponsor
Associate Sponsor
Conference Sponsor
Luncheon Sponsor
Media Partners
Sponsor Opportunities
With conferences in the United States, Europe, Asia Pacific, and Latin America, the C5 Group of Companies: American Conference Institute, the Canadian Institute, and C5 Group, provides a diverse portfolio of conferences, events and roundtables devoted to providing business intelligence to senior decision makers responding to challenges around the world.
For more information please contact:
Aaron Goldstein
Senior Business Development Manager
Email: [email protected]